x

SIGA TECHNOLOGIES INC (Nasdaq:SIGA)

Health Care/Life Sciences • Pharmaceuticals
CIK 1010086
Company

SIGA Technologies, Inc. is a commercial-stage pharmaceutical company, which engages in the development and commercialization of solutions for serious unmet medical needs and biothreats. The firm develops therapeutic solutions for lethal pathogens including smallpox, Ebola, dengue, Lassa fever, and other dangerous viruses. It offers an orally administered antiviral drug that targets orthopoxviruses under the TPOXX brand. The company was founded by Steven Oliveira on December 28, 1995 and is headquartered in New York, NY.

Address
31 East 62nd Street
New York, New York 10065
Employees
39
Stock Info
Close
$4.8600
Day Range
4.8500 - 5.0400
52 Week Range
4.2150 - 6.7000
Average volume
356.05K
Short Interest
5.05M (02/15/24)
% of Float Shorted
12.54%
Market Cap
$345.51M
Revenue
$110.78M
Net Income
$33.9M
2020 Sales Growth
N/A
Rev. per Employee
$892.17K
P/E Ratio
N/A
EPS
-$0.0699
Yield
0.00%
Dividend
$0.4500
Ex-Dividend Date
May 15, 2023
Key Executives
Board Of Directors
Chief Executive Officer & Director
Diem Nguyen PhD, MBA
Director & Chief Medical Officer
Jay Kumar Varma MD
Director
Harold E Ford Jr.
Independent Director
Jaymie A Durnan
Independent Director
Julian Nemirovsky MBA
Independent Director
Joseph W Marshall III
Independent Director
Gary J Nabel MD, PhD
Independent Director
Holly L Phillips MD
SEC filings
DateFormEvent
13 Dec, 2024 8-K
10 Dec, 2024 8-K
8 Nov, 2024 SC 13G
7 Nov, 2024 8-K
7 Nov, 2024 10-Q
29 Oct, 2024 4
24 Oct, 2024 SC 13G
4 Oct, 2024 8-K
23 Sep, 2024 8-K
20 Sep, 2024 8-K
15 Aug, 2024 8-K
1 Aug, 2024 8-K
1 Aug, 2024 10-Q
19 Jul, 2024 8-K
3 Jul, 2024 4
3 Jul, 2024 4
13 Jun, 2024 4
13 Jun, 2024 4
13 Jun, 2024 4
13 Jun, 2024 4
13 Jun, 2024 8-K
13 Jun, 2024 4
13 Jun, 2024 4
13 Jun, 2024 4
13 Jun, 2024 4
7 May, 2024 8-K
7 May, 2024 10-Q
26 Apr, 2024 DEFA14A
26 Apr, 2024 DEF 14A
26 Apr, 2024 ARS
1 Apr, 2024 8-K
27 Mar, 2024 3
27 Mar, 2024 4
12 Mar, 2024 8-K
12 Mar, 2024 10-K
1 Feb, 2024 SC 13G
30 Jan, 2024 3
30 Jan, 2024 4
22 Jan, 2024 8-K CEO Change
2 Jan, 2024 8-K
7 Nov, 2023 8-K
7 Nov, 2023 10-Q
6 Sep, 2023 8-K
8 Aug, 2023 10-Q
8 Aug, 2023 8-K
28 Jul, 2023 8-K
28 Jul, 2023 8-K
15 Jun, 2023 3
15 Jun, 2023 4
15 Jun, 2023 8-K
15 Jun, 2023 4
15 Jun, 2023 4
15 Jun, 2023 4
15 Jun, 2023 4
15 Jun, 2023 4
15 Jun, 2023 4
15 Jun, 2023 4
12 May, 2023 4
12 May, 2023 4
4 May, 2023 10-Q
4 May, 2023 8-K
4 May, 2023 8-K
26 Apr, 2023 ARS
26 Apr, 2023 DEF 14A
2 Mar, 2023 10-K
2 Mar, 2023 8-K
14 Feb, 2023 SC 13G/A
17 Jan, 2023 8-K CEO Change
14 Nov, 2022 8-K
14 Nov, 2022 3
14 Nov, 2022 3
14 Nov, 2022 4
14 Nov, 2022 4
3 Nov, 2022 8-K
3 Nov, 2022 10-Q
9 Aug, 2022 8-K
4 Aug, 2022 8-K
4 Aug, 2022 10-Q
12 Jul, 2022 8-K
24 Jun, 2022 SC 13G
16 Jun, 2022 4
16 Jun, 2022 4
16 Jun, 2022 4
16 Jun, 2022 4
16 Jun, 2022 4
16 Jun, 2022 8-K
16 Jun, 2022 4
16 Jun, 2022 4
16 Jun, 2022 4
5 May, 2022 10-Q
5 May, 2022 8-K
27 Apr, 2022 DEF 14A
13 Apr, 2022 PRE 14A
24 Mar, 2022 8-K
3 Mar, 2022 10-K
3 Mar, 2022 8-K
9 Feb, 2022 SC 13G/A
1 Feb, 2022 SC 13G/A
15 Dec, 2021 8-K
10 Dec, 2021 4
22 Nov, 2021 SC 13D/A
4 Nov, 2021 8-K
4 Nov, 2021 10-Q
17 Sep, 2021 SC 13D/A
15 Sep, 2021 8-K
9 Sep, 2021 8-K
17 Aug, 2021 SC 13D/A
5 Aug, 2021 8-K
5 Aug, 2021 10-Q
3 Aug, 2021 4
3 Aug, 2021 4
17 Jun, 2021 3
17 Jun, 2021 4
17 Jun, 2021 4
17 Jun, 2021 4
17 Jun, 2021 4
17 Jun, 2021 4
17 Jun, 2021 4
17 Jun, 2021 4
17 Jun, 2021 4
17 Jun, 2021 4
17 Jun, 2021 3
17 Jun, 2021 8-K
17 Jun, 2021 4
6 May, 2021 8-K
6 May, 2021 10-Q
27 Apr, 2021 DEF 14A
4 Mar, 2021 10-K
4 Mar, 2021 8-K
23 Feb, 2021 SC 13D
1 Feb, 2021 SC 13G/A
22 Jan, 2021 8-K
13 Jan, 2021 8-K
4 Jan, 2021 SC 13G/A
Last update:2024-03-11 12:04:49.725159

Sign Up to Subscribe